ARWR — Arrowhead Pharmaceuticals Inc
In 2026 Q2, 5 of the 140 tracked hedge funds reported a position in Arrowhead Pharmaceuticals Inc (ARWR), worth $56.03M combined. Over the quarter 2 opened or added, 4 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $38.22M | 0.05% | -54.8% |
| VanEck | $9.09M | 0.00% | +490.3% |
| Keystone | $7.72M | 0.41% | +63.5% |
| Kohlberg | $957.96K | 0.02% | NO CHANGE |
| Persistent | $39.29K | 0.01% | -81.9% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.